AMAG Pharmaceuticals, Inc.
(NASDAQ : AMAG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -1.06%36.310.9%$1706.89m
ABBVAbbVie, Inc. 1.74%102.591.9%$1015.37m
JNJJohnson & Johnson -1.03%144.850.7%$999.82m
LLYEli Lilly & Co. -1.80%142.871.1%$686.51m
MRKMerck & Co., Inc. -0.09%80.380.7%$677.65m
BMYBristol-Myers Squibb Co. -0.06%61.581.0%$659.19m
AZNAstraZeneca Plc -3.04%53.621.2%$259.47m
GSKGlaxoSmithKline Plc -0.70%36.770.2%$230.09m
NVSNovartis AG -0.26%87.290.2%$169.47m
NVONovo Nordisk A/S -0.87%67.000.1%$92.14m
RGENRepligen Corp. -1.23%191.137.1%$91.87m
SNYSanofi -0.87%50.080.2%$68.89m
RPRXRoyalty Pharma Plc 0.92%40.740.2%$65.49m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -5.37%92.870.0%$63.42m
TPTXTurning Point Therapeutics, Inc. 0.40%103.510.0%$55.06m

Company Profile

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.